In this episode, Prof. Susanne Lau and Prof. Marcus Maurer discuss biologics in dermatology. This episode was recorded at the EUFOREUM 'Respiratory care in Type 2 driven diseases: From childhood to adulthood' meeting in Berlin (Germany) in November 2023.

Prof. Susanne Lau and Prof. Eckard Hamelmann take part in our second episode of ON AIR with EUFOREA to discuss the remission of type 2 inflammation. This episode was recorded at the EUFOREUM 'Respiratory care in Type 2 driven diseases: From childhood to adulthood' meeting in Berlin (Germany) in November 2023.

Episode 3 is on the prevention in Type 2 inflammation-driven diseases with special guests Prof. Susanne Lau & Prof. Monika Gappa. This episode was recorded at the EUFOREUM 'Respiratory care in Type 2 driven diseases: From childhood to adulthood' meeting in Berlin (Germany) in November 2023.

Prof. Peter Hellings, EUFOREA Founder and Chairman, chats with Dr Dermot Ryan about his "Expert Vision for the Future of Chronic Respiratory Diseases". This episode was recorded at the EUFOREUM 'Respiratory care in Type 2 driven diseases: From childhood to adulthood' meeting in Berlin (Germany) in November 2023.

This podcast was recorded at the 1st edition of EUFOREA's European Biologics Training Course that took place on 1 March 2024 in Brussels, with special guests Prof. Peter Hellings (EUFOREA Founder and Chairman) and Prof. Ian Pavord (EUFOREA Asthma Expert Panel Member).

Understand what could be left to improve for patients suffering from CRSwNP and learn the experiences/perspectives of our podcast's guests dealing not only with patients but also with HCPs who have a low understanding of the disease.

This podcast was recorded at the 1st edition of EUFOREA's European Biologics Training Course that took place on 1 March 2024 in Brussels, with special guests Prof. Wytske Fokkens (EUFOREA EPOS/CRS Expert Panel Chair) and Prof. Anju Peters (EUFOREA EPOS/CRS Expert Panel Member).

Nowadays, there are several asthma treatment options to follow, however, not many of these treatments can address all the patient's needs.

Listen to Prof. Wytske Fokkens (The Netherlands) and Prof. Michael Wechsler (USA) and understand their views on the future of asthma care.

How is the journey of a patient suffering from chronic rhinosinusitis with nasal polyps (CRSwNP)?

Mrs Elizabeth Van Staeyen, Scientific Communications & Advocacy Manager at EUFOREA interviews Mr Andrew Knill, to understand Andrew's journey as a CRSwNP patient and how he became empowered to become an advocate!